In the rapidly evolving landscape of biotechnology, collaboration with Contract Research Organizations (CROs) is essential for successful clinical trials. However, it does not come without risk: upfront investment, hidden costs, and misaligned financial priorities to name a few. Effective financial management is crucial to ensure timely and accurate project execution, as well as audit preparedness. Here are best practices to enhance your partnership with CROs and optimize your clinical trial finances.

1. Establish Clear Contracts and Set Expectations

Define specific financial deliverables, timelines, and performance metrics in your vendor contract to avoid misunderstandings. Discuss expectations for reporting early to ensure continuous and timely flow of information throughout the study.

2. Regular Financial Reconciliation

Ensure frequent reconciliation between the CRO’s reported costs and your internal financial records. This helps prevent discrepancies and ensures that financial reports remain accurate and audit-ready.

→ Essential Reporting for Financial Health

To maintain optimal financial oversight when working with your CRO, ensure you have access to the following critical reports:

CRO Unit/Work Completed Tracker

• Require detailed, line-item level tracking from your CRO for direct fees (regardless of fixed-price or milestone-based contracts), along with transaction-level tracking for pass-through and investigator fees.
  • Milestone payments do not accurately reflect the work completed, but rather are a tool for cashflow management. A comprehensive tracker for direct fees, pass-through costs, and investigator fees ensures transparency and alignment with the CRO’s estimate of expenses incurred, and will be required by auditors.
• Reporting should be monthly or quarterly, in alignment with your financial reporting cycle, and include a detailed task-by-task breakdown of units performed by the CRO. 

Subject Visit Report

• Track patient metrics: screenings, enrollments, active participation, and completions.
• Use this data to accurately estimate investigator grants and verify CRO invoicing, especially for site and patient-related payments.

Additional Support Reports

• Screen Failure Report: Insight into patient drop-off rates.
• Unscheduled Visits Report: Track unexpected patient interactions.
• Invoiceables/Procedures Report: Ensure all billable activities are accounted for.

Site Listing

• Monitor recruitment, activation, and closure of study sites.
• Independently verify CRO reports to validate milestone payments.

IMV Report

• Assess your CRO’s monitoring activities and their completion status.
• Cross-reference this data to ensure accurate invoicing.

3. Collaborate on Budget Forecasting

Work closely with the CRO and other internal teams to develop accurate, realistic budgets, and update forecasts regularly. Integrating real-time data from both the CRO and internal teams can help monitor and adjust for any unexpected costs.

4. Use Integrated Financial Tools

Leverage financial software platforms that support real-time data exchange, automated accruals, and compliance tracking. This reduces manual errors and keeps finance teams aligned with clinical progress.

5. Establish a Communication and Reporting Cadence

Establish regular check-ins and reporting schedules with the CRO to stay updated on trial progress and financial impacts. Regular updates can prevent last-minute budget surprises and align the CRO’s work with financial goals.

→ Why an Invoice Isn’t Enough

CRO invoices are notoriously opaque. It is not uncommon to receive a multi-million dollar invoice with a single line item: Project Management.

To safeguard your finances:

• Request Line-Level Detail: During the study start-up and work order negotiation, ask for detailed reporting before invoicing. This helps confirm expenses against your independent, activity-based estimates.
• Leverage Real Study Data: If there are discrepancies, use your detailed expense estimates to discuss variances with your CRO.

6. Define Risk Management Protocols

Plan for potential cost overruns and delays by building contingency funds and risk management strategies into the budget. This ensures financial flexibility when dealing with unexpected clinical outcomes.

Avoid the black box, and be proactive in managing change orders to prevent unexpected costs and surprise retrospective invoices:

• Identify Hidden Costs: Watch for price increases, volume changes, mistakes, and duplicate items.
• Perform Line-Level Comparisons: Analyze your current work order against any upcoming changes. Use tools like specialized software to simplify your review.
• Validate New Additions: Ensure any new line items are indeed necessary and avoid unnecessary duplication.

Conclusion: Trust but verify

Navigating the complexities of clinical trials requires a strategic approach to financial management, especially when partnering with CROs. Establishing clear contracts, maintaining robust financial oversight, and fostering open communication, allows clinical finance organizations to enhance collaboration with CROs and mitigate financial risks. By prioritizing transparency and proactive planning, you can ensure that your partnership with CROs not only meets your financial goals but also supports the broader mission of advancing innovative therapies.

‍